术前睾酮替代治疗与全膝关节置换术后并发症风险增加相关:一项13,250例患者的倾向性匹配分析
本研究基于大型全国数据库的回顾性队列研究,纳入2020年2月前接受初次全膝关节置换术且有5年随访的患者,按术前一年内是否使用睾酮替代治疗分组,经1:1倾向性评分匹配后每组6,625例。结果显示术前睾酮替代治疗与术后90天、1年及5年的多种内科和假体周围并发症风险升高相关。
要点
- 术前使用睾酮替代治疗与全膝关节置换术后90天肺栓塞、肺炎、急性肾损伤和脓毒症风险升高相关。
- 术后1年,睾酮替代治疗组深静脉血栓、心脏事件和肺炎风险升高。
- 术后5年,睾酮替代治疗组假体周围感染、假体周围骨折和翻修手术风险升高。
核心结论
- 术前使用睾酮替代治疗与全膝关节置换术后并发症风险增加相关。
研究设计与样本
- 回顾性队列研究,使用大型全国数据库,纳入2020年2月前接受初次全膝关节置换术且有5年随访的患者。
- 排除有化脓性关节炎、骨坏死或病理性骨折病史的患者,按术前一年内是否使用睾酮替代治疗分组,采用1:1倾向性评分匹配平衡队列。
- 匹配后每组纳入6,625例患者。
主要发现
- 术后90天,睾酮替代治疗组肺栓塞(OR 1.4,95%CI:1.0至1.8,P=0.041)、肺炎(OR 1.8,95%CI:1.4至2.3,P<0.001)、急性肾损伤(OR 1.5,95%CI:1.2至1.8,P<0.001)和脓毒症(OR 1.8,95%CI:1.3至2.4,P<0.001)发生率更高。
- 术后1年,睾酮替代治疗组深静脉血栓(OR 1.4,95%CI:1.1至1.6,P<0.001)、心脏事件(OR 1.3,95%CI:1.0至1.6,P=0.018)和肺炎(OR 1.6,95%CI:1.3至1.8,P<0.001)发生率升高。
- 术后5年,睾酮替代治疗组假体周围感染(OR 2.3,95%CI:1.8至2.8,P<0.001)、假体周围骨折(OR 2.7,95%CI:1.9至4.0,P<0.001)和翻修手术(OR 1.5,95%CI:1.2至1.8,P<0.001)风险增加。
关键数值与推荐
- 术后90天肺栓塞OR 1.4(95%CI:1.0至1.8,P=0.041),肺炎OR 1.8(95%CI:1.4至2.3,P<0.001),急性肾损伤OR 1.5(95%CI:1.2至1.8,P<0.001),脓毒症OR 1.8(95%CI:1.3至2.4,P<0.001)。
- 术后1年深静脉血栓OR 1.4(95%CI:1.1至1.6,P<0.001),心脏事件OR 1.3(95%CI:1.0至1.6,P=0.018),肺炎OR 1.6(95%CI:1.3至1.8,P<0.001)。
- 术后5年假体周围感染OR 2.3(95%CI:1.8至2.8,P<0.001),假体周围骨折OR 2.7(95%CI:1.9至4.0,P<0.001),翻修手术OR 1.5(95%CI:1.2至1.8,P<0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: While testosterone replacement therapy (TRT) is known to affect cardiovascular physiology, its impact on outcomes following total knee arthroplasty (TKA) remains unclear. This study aimed to assess whether preoperative TRT use is associated with increased complications following TKA. METHODS: A retrospective cohort study using a large national database was performed. Patients undergoing primary TKA before February 2020 with 5-year follow-up were stratified based on preoperative TRT use within one year of surgery. Patients who had a history of septic arthritis, osteonecrosis, or pathologic fractures were excluded. Propensity score matching (1:1) was used to balance cohorts. Outcomes included medical complications at 90 days and one year postoperatively and periprosthetic complications up to five years postoperatively. After matching, 6,625 patients were included in each cohort. RESULTS: At 90 days, TRT use was associated with higher rates of pulmonary embolism (odds ratio (OR) 1.4, 95% confidence interval (CI): 1.0 to 1.8, P = 0.041), pneumonia (OR 1.8, 95% CI: 1.4 to 2.3, P < 0.001), acute kidney injury (OR 1.5, 95% CI: 1.2 to 1.8, P < 0.001), and sepsis (OR 1.8, 95% CI: 1.3 to 2.4, P < 0.001). At one year, TRT patients had elevated deep vein thrombosis (OR 1.4, 95% CI: 1.1 to 1.6, P < 0.001), cardiac event (OR 1.3, 95% CI: 1.0 to 1.6, P = 0.018), and pneumonia (OR 1.6, 95% CI: 1.3 to 1.8, P < 0.001) rates. At five years, TRT use was associated with increased periprosthetic joint infections (OR 2.3, 95% CI: 1.8 to 2.8, P < 0.001), periprosthetic fractures (OR 2.7, 95% CI: 1.9 to 4.0, P < 0.001), and revision surgeries (OR 1.5, 95% CI: 1.2 to 1.8, P < 0.001). CONCLUSIONS: Preoperative TRT use was associated with increased risk of complications following TKA.
引用
- Omurzakov A, Omurzakov AM, Bhatti P, et al. Preoperative Testosterone Replacement Therapy Is Associated With Increased Complication Risk After Total Knee Arthroplasty: A Propensity-Matched Analysis of 13,250 Patients. J Arthroplasty. 2025. PMID: 41177190. doi:10.1016/j.arth.2025.10.066
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。